{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:08:53Z","timestamp":1791407333327,"version":"4.3.3"},"reference-count":63,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"vor","delay-in-days":4003,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[1998,9,10]]},"abstract":"<jats:p><jats:bold>Summary\u2014<\/jats:bold>Dextromethorphan (DM), a widely used and well\u2010tolerated centrally acting antitussive, has been tested in several clinical trials for its antiepileptic and neuroprotective properties. However, the use of DM in these new clinical indications requires higher doses than antitussive doses, which may therefore induce phencyclidine (PCP)\u2010like side\u2010effects (memory and psychotomimetic disturbances) through its metabolic conversion to the active metabolite dextrorphan (DX), a more potent PCP\u2010like non\u2010competitive antagonist at the N\u2010methyl\u2010D\u2010aspartate (NMDA) receptor than DM. Thus, we compared the behavioural effects in rats of intraperitoneal administration of DM and DX on motor activity in an open field and on learning and memory in the Morris water maze. DM (20, 30, 40 mg\/kg) produced a dose\u2010dependent decrease in both locomotion and stereotyped behaviour with a slight ataxia for the highest dose. DX (20, 30,40 mg\/kg) induced a dose\u2010dependent increase in locomotion and stereotypies (swaying, turning) with moderate ataxia. Assessments of learning and memory were performed with lower doses of DM (10, 20, 30 mg\/kg) and DX (5, 10, 15 mg\/kg) because of motivational deficits (40 mg\/kg of DM, 20\u201340 mg\/kg of DX) and motor disorders (30, 40 mg\/kg of DX) in the cue learning procedure. DX (10, 15 mg\/kg) impaired spatial learning with a long\u2010lasting effect for the highest dose whereas 5 mg\/kg of DX and DM (10\u201330 mg\/kg) did not. Only 15 mg\/kg of DX appeared to slightly impair working memory. DM (10\u201330 mg\/kg) and DX (5\u201315 mg\/kg) did not impair reference memory. Thus, the two antitussives DM and DX induced different behavioural effects suggesting sedative effects for DM and PCP\u2010like effects for DX. However, PCP\u2010like side\u2010effects with DM remain possible through its metabolic conversion to DX, with very high doses and\/or in extensive metabolizers and\/or in aged subjects prone to cognitive dysfunction. Therefore, the identification of DM metabolism phenotype, an adapted prescription and a pharmacological modulation of the DM metabolism may avoid adverse effects.<\/jats:p>","DOI":"10.1111\/j.1472-8206.1998.tb00982.x","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T17:30:50Z","timestamp":1251307850000},"page":"526-537","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Dextromethorphan and dextrorphan in rats: Common antitussives \u2014 Different behavioural profiles"],"prefix":"10.1111","volume":"12","author":[{"given":"M","family":"Dematteis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lallement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mallaret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.26.2.254"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199212000-00009"},{"key":"e_1_2_1_4_2","first-page":"73","article-title":"Neuropharmacological effects of sigma receptor ligands: anxiolytic, anti\u2010amnesic and neuroprotective effects","volume":"16","author":"Amano M","year":"1996","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.2.197"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00056-8"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199207030-00004"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/361031a0"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)00916-X"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92466-S"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/00207458909002151"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005011"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490240224"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0022-3565(25)38717-3","article-title":"Many agents that antagonize the NMDA receptor\u2010channel complex in vivo also cause disturbances of motor coordination","volume":"269","author":"Carter AJ.","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90386-9"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)90506-1"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)00682-4"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)90529-0"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6547.597"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0022-3565(25)10415-1","article-title":"Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humans","volume":"263","author":"Funck\u2010Brentano C","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0753-3322(96)82690-4"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82559-4"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245517"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-3565(25)32225-1","article-title":"Phencyclidine\u2010like discriminative effects of opioids in the rat","volume":"214","author":"Holtzman SG.","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3565(25)05201-2","article-title":"Actions and addiction liabilities of dromoran derivatives in man","volume":"107","author":"Isbell H","year":"1953","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198910000-00001"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0022-3565(25)11473-0","article-title":"High\u2010affinity dextromethorphan and (+)\u20103\u2010(\u20103\u2010hydroxyphenyl)\u2010N\u2010(1\u2010propyl)piperidine binding sites in rat brain. Allosteric effects of ropizine","volume":"260","author":"Klein M","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)01103-X"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00518181"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(93)90198-U"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403033300907"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90847-B"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90015-A"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)91397-8"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0173(93)90006-L"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701043"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3758\/BF03327134","article-title":"The effects of hippocampal lesions on two neotic choice tasks","volume":"21","author":"Mitchell D","year":"1993","journal-title":"Psychobiology"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb14637.x"},{"key":"e_1_2_1_39_2","first-page":"405","volume-title":"Molecular, Cellular and Behavioural Neurobiology of the Hippocampus","author":"Morris RGM.","year":"1983"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(84)90007-4"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90969-O"},{"key":"e_1_2_1_42_2","first-page":"695","volume-title":"Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?","author":"Murray TF","year":"1992"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90849-D"},{"key":"e_1_2_1_44_2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0022-3565(25)10500-4","article-title":"Effects of intrahippocampal injections of N\u2010methyl\u2010D\u2010aspartate receptor antagonists and scopolamine on working and reference memory assessed in rats by a three\u2010panel runway task","volume":"263","author":"Ohno M","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00749-7"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600670939"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90059-Q"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244550"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.3.333"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-6757(91)90085-X"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90780-T"},{"key":"e_1_2_1_52_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1542\/peds.59.1.117","article-title":"Dextromethorphan toxicity: reversal by Naloxone","volume":"59","author":"Shaul WL","year":"1977","journal-title":"Pediatrics"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90279-6"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(91)90569-N"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0700943"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(89)90050-3"},{"key":"e_1_2_1_57_2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-3565(25)39004-X","article-title":"Novel anti\u2010convulsant analogs of dextromethorphan: Improved efficacy, potency, duration and side\u2010effect profile","volume":"268","author":"Tortella FC","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6882.896"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00441949"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(90)90150-7"},{"key":"e_1_2_1_61_2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0022-3565(25)10693-9","article-title":"Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat","volume":"274","author":"Wu D","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)00729-Q"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.77"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(91)90108-T"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.1998.tb00982.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.1998.tb00982.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:32:52Z","timestamp":1739309572000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.1998.tb00982.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9,10]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,9,10]]}},"alternative-id":["10.1111\/j.1472-8206.1998.tb00982.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.1998.tb00982.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9,10]]},"assertion":[{"value":"2009-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}